Clinical trial
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in…
NCT00368472 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00368472 |
|---|---|
| Title | 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures |
| Official title | An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 (Perampanel) as an Adjunctive Therapy in Patients With Refractory Partial Seizures |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Perampanel |
| Enrollment | 138 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Aug 24, 2006 |
| Last update posted | Dec 10, 2015 |
| Countries | Australia, Belgium, Czechia, Estonia, Finland, France, Germany, Latvia, Lithuania, Netherlands, Spain, Sweden and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: